RECRUITING

Alcohol Research in HIV: Relapse Prevention

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person delivered relapse prevention intervention.

Official Title

Alcohol Research Consortium in HIV: Relapse Prevention Arm

Quick Facts

Study Start:2023-03-27

Study Completion:2026-05-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05163301

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Confirmed diagnosis of HIV * Aged 18 years or older * Must be enrolled in clinical care at Johns Hopkins HIV Clinic. 1. lifetime alcohol use disorder 2. patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical care that show in the last 3 years: periods of no or lower risk drinking (e.g. women/men who are drinking \<11/22 drinks per week) and periods of lapse to higher levels of drinking (=\>11/22 drinks per week for women/men) 3. current PRO showing alcohol abstinence or alcohol use at \<11/22 drinks per week for women/men.	* Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent * Non-English speaking because interventions are currently available in English only

Inclusion Criteria

Exclusion Criteria

* Confirmed diagnosis of HIV
* Aged 18 years or older
* Must be enrolled in clinical care at Johns Hopkins HIV Clinic.
1. lifetime alcohol use disorder
2. patient reported outcomes (PRO) assessment collected by the Center for AIDS Research (CFAR) Network of Clinical Systems as part of usual clinical care that show in the last 3 years: periods of no or lower risk drinking (e.g. women/men who are drinking \<11/22 drinks per week) and periods of lapse to higher levels of drinking (=\>11/22 drinks per week for women/men)
3. current PRO showing alcohol abstinence or alcohol use at \<11/22 drinks per week for women/men.

* Acutely suicidal, homicidal, psychotic or otherwise unable to provide informed consent
* Non-English speaking because interventions are currently available in English only

Contacts and Locations

Study Contact

Heidi Hutton, PhD

CONTACT

14104586715

hhutton@jhmi.edu

Principal Investigator

Heidi Hutton, PhD

PRINCIPAL_INVESTIGATOR

Johns Hopkins School of Medicine

Study Locations (Sites)

Johns Hopkins School of Medicine

Baltimore, Maryland, 21287

United States

Collaborators and Investigators

Sponsor: Johns Hopkins University

Heidi Hutton, PhD, PRINCIPAL_INVESTIGATOR, Johns Hopkins School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-03-27

Study Completion Date2026-05-31

Study Record Updates

Study Start Date2023-03-27

Study Completion Date2026-05-31

Terms related to this study

Additional Relevant MeSH Terms

HIV
Alcohol Use Disorder